Article Information
History
- May 5, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Patrizia Mancuso1,#,
- Antonio Gidaro2,#,
- Giuliana Gregato1,
- Alessandro Raveane1,
- Paola Cremonesi1,
- Jessica Quarna1,
- Sonia Caccia2,
- Luca Gusso2,
- Chiara Cogliati2 and
- Francesco Bertolini1,*
- 1Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan, Italy
- 2ASST Fatebenefratelli Sacco, Department of Biomedical and Clinical Sciences, “Luigi Sacco” Hospital, University of Milan, Milan, Italy
- ↵*Corresponding author: Francesco Bertolini, MD, PhD, Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, Milan, Italy, Email: francesco.bertolini{at}ieo.it
↵# Contributed equally to this work
Posted May 05, 2020.
Viable circulating endothelial cells and their progenitors are increased in Covid-19 patients
